Quantcast

Latest Kidney transplantation Stories

2014-06-03 16:25:04

HORSHOLM, Denmark, June 3, 2014 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) today announced the hiring of senior level management in preparation for potential U.S. commercialization of Envarsus(®) XR (tacrolimus extended-release tablets) an investigational new drug under FDA review for the prevention of organ rejection in adult kidney transplant patients. Key points: -- Envarsus( )XR is an extended release formulation of tacrolimus being designed for once-daily...

2014-05-29 12:28:41

WASHINGTON, May 29, 2014 /PRNewswire-USNewswire/ -- On May 30(th), nephrologists and kidney patients from across the country will convene in Washington to participate in the Renal Physicians Association's (RPA) annual Capitol Hill Day. Coordinated in collaboration with the American Association of Kidney Patients (AAKP), RPA's Capitol Hill day offers kidney patients and nephrologists the opportunity to advocate on issues impacting the delivery of effective and appropriate kidney disease...

2014-05-22 23:16:21

New book tells of an extraordinary comeback from kidney failure to good health. London (PRWEB) May 22, 2014 Adeleke Eniola Oyenusi’s recovery from kidney failure inspired him to write his new book “Living a Normal and Healthy Life after Renal (Kidney) Failure” (published by Trafford Publishing) to encourage and educate other renal patients with little or no knowledge about the condition. “I asked my wife to quickly rush me to the hospital when I became breathless and feared I...

2014-05-22 04:21:28

HORSHOLM, Denmark, May 22, 2014 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the granting of a marketing authorization for Envarsus® for the prevention of organ rejection in adult transplant patients in the European Union (EU). The positive opinion is for both kidney and liver transplant recipients and includes both the...

2014-05-01 12:32:14

WASHINGTON, May 1, 2014 /PRNewswire-USNewswire/ -- Today RPA joins 14 other kidney organizations to promote changes in kidney care on Capitol Hill. Participants in Kidney Community Advocacy Day represent health professionals and kidney patients and will meet with elected officials and their staff to discuss issues that will improve the treatment and quality of life for millions of Americans: increasing federal investment in kidney research, and extending lifetime immunosuppressive drug...

2014-04-29 23:12:43

The heart and liver transplantation programs at Allegheny General Hospital (AGH), part of the Allegheny Health Network, are the region’s best in patient care quality, according to the latest report by the Scientific Registry of Transplant Recipients (SRTR). Pittsburgh, PA (PRWEB) April 29, 2014 The heart and liver transplantation programs at Allegheny General Hospital (AGH), part of the Allegheny Health Network, are the region’s best in patient care quality, according to the latest...

2014-04-28 16:31:53

Daughter Donates Kidney to Mother in Hollywood, Florida HOLLYWOOD, Fla., April 28, 2014 /PRNewswire/ -- This month not only marks Mother's Day for Michele Giordano, but also her 55(th) birthday, and she will be celebrating the most precious gift of all--the kidney she will be receiving in a living-donor transplant from her 22-year-old daughter, Jenna. The 22-year-old is honoring her mother by giving her the gift of life. "I feel incredibly blessed and happy to have someone who...

2014-04-28 12:31:12

- Study published online in Liver Transplantation - HORSHOLM, Denmark, April 28, 2014 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) today announced the publication of a Phase II study demonstrating conversion from twice-daily tacrolimus to once-daily Envarsus(®) in stable liver transplant patients in Liver Transplantation. Key points: -- Envarsus(®) is an extended release formulation of tacrolimus designed for once-daily dosing, flatter pharmacokinetics and greater...

2014-04-17 23:13:10

CPMC liver, kidney transplant programs earn recognition from transplant registry Sutter Health affiliate transplant team’s risk-adjusted survival rate is nation’s best. SAN FRANCISCO (PRWEB) April 17, 2014 Sutter Health affiliate California Pacific Medical Center (CPMC) has been identified as the nation’s only hospital with both kidney and liver transplant programs that have higher-than-expected one- and three-year adult patient survivals that are statistically better-than-expected....

2014-04-15 08:31:27

NEW YORK, April 15, 2014 /PRNewswire-USNewswire/ -- The National Kidney Foundation (NKF) announced today, during National Donate Life Month, that Astellas Pharma US, Inc. was named the first-ever National Presenting Sponsor for the Kidney Walk. Through this partnership, Astellas will support more than 85 Kidney Walk events being held in major cities across the country. "Our partnership with NKF exemplifies what Astellas and these walks are all about - enabling patients to be their own...


Latest Kidney transplantation Reference Libraries

2011-01-05 16:14:54

The BK virus, a member of the polyomavirus family, has no major consequences of infected except with those that are immunocomprimised or immunosuppressed. The virus was first isolated in 1971 from the urine sample of a renal transplant patient whose initials were B.K. Similar in genome sequences to the JCV virus they are most easily identified and differentiated from each other through serological tests using specific antibodies or through PCR based genotyping approach. Most people are...

More Articles (1 articles) »
Word of the Day
kenspeckle
  • Having so marked an appearance as easily to be recognized.
This word may come from the Swedish 'kanspak,' quick at recognizing persons or things, or else from confusion with 'conspicuous.'